1. Home
  2. MSBI vs RGNX Comparison

MSBI vs RGNX Comparison

Compare MSBI & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MSBI
  • RGNX
  • Stock Information
  • Founded
  • MSBI 1881
  • RGNX 2008
  • Country
  • MSBI United States
  • RGNX United States
  • Employees
  • MSBI N/A
  • RGNX N/A
  • Industry
  • MSBI Major Banks
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MSBI Finance
  • RGNX Health Care
  • Exchange
  • MSBI Nasdaq
  • RGNX Nasdaq
  • Market Cap
  • MSBI 505.5M
  • RGNX 459.1M
  • IPO Year
  • MSBI 2016
  • RGNX 2015
  • Fundamental
  • Price
  • MSBI $26.55
  • RGNX $11.23
  • Analyst Decision
  • MSBI Hold
  • RGNX Strong Buy
  • Analyst Count
  • MSBI 4
  • RGNX 11
  • Target Price
  • MSBI $26.75
  • RGNX $37.80
  • AVG Volume (30 Days)
  • MSBI 91.7K
  • RGNX 507.4K
  • Earning Date
  • MSBI 10-24-2024
  • RGNX 11-06-2024
  • Dividend Yield
  • MSBI 4.62%
  • RGNX N/A
  • EPS Growth
  • MSBI N/A
  • RGNX N/A
  • EPS
  • MSBI 2.29
  • RGNX N/A
  • Revenue
  • MSBI $259,944,000.00
  • RGNX $84,327,000.00
  • Revenue This Year
  • MSBI N/A
  • RGNX $7.85
  • Revenue Next Year
  • MSBI $0.04
  • RGNX $217.02
  • P/E Ratio
  • MSBI $11.71
  • RGNX N/A
  • Revenue Growth
  • MSBI N/A
  • RGNX N/A
  • 52 Week Low
  • MSBI $20.54
  • RGNX $8.54
  • 52 Week High
  • MSBI $28.47
  • RGNX $28.80
  • Technical
  • Relative Strength Index (RSI)
  • MSBI 65.87
  • RGNX 58.40
  • Support Level
  • MSBI $23.10
  • RGNX $8.54
  • Resistance Level
  • MSBI $28.06
  • RGNX $9.87
  • Average True Range (ATR)
  • MSBI 0.90
  • RGNX 0.52
  • MACD
  • MSBI 0.29
  • RGNX 0.12
  • Stochastic Oscillator
  • MSBI 70.90
  • RGNX 75.14

About MSBI Midland States Bancorp Inc.

Midland States Bancorp Inc is a diversified financial holding company. The company provides a full range of commercial and consumer banking products and services, business equipment financing, merchant credit card services, trust and investment management, and insurance and financial planning services. The Banking segment which generates the majority of the revenue, provides a wide range of financial products and services to consumers and businesses, including commercial, commercial real estate, mortgage and other consumer loan products; commercial equipment financing etc. The Wealth Management segment consists of trust and fiduciary services, brokerage and retirement planning services. The Other segment includes the operating results of the parent company.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

Share on Social Networks: